Roger Pomerantz, President and CEO at Seres Therapeutics, Inc. (MCRB), sold 20,000 shares at $35.00 ($700K) on 2016-07-27, disclosed to the SEC on 2016-07-28.
Open-market sale of $700k MCRB by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RUBY | BUY | 2018-07-23 | $2K | — | Filing → |
| MCRB | SELL | 2018-07-12 | $9K | — | Filing → |
| MCRB | SELL | 2018-07-10 | $590K | — | Filing → |